Darzalex Faspro 1800mg (Daratumumab) Liquid for Injection Darzalex Faspro 1800 mg Injection contains Daratumumab, a monoclonal antibody used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. Daratumumab is an immunotherapy medicine that helps the immune system identify and destroy cancer cells. Darzalex Faspro is a subcutaneous formulation of Daratumumab combined with hyaluronidase, allowing faster administration compared to traditional intravenous infusions. Ernest Oncology supplies Darzalex Faspro 1800mg (Daratumumab) Liquid for Injection globally with secure packaging, competitive export pricing, and reliable worldwide delivery. Product Information (Text Format) Product Name: Darzalex Faspro Injection Generic Name: Daratumumab Strength: 1800mg Dosage Form: Liquid for Injection Therapeutic Class: Anti-Cancer / Immunotherapy / Monoclonal Antibody Packaging Type: Vial Route of Administration: Subcutaneous Injection Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Darzalex Faspro 1800mg Injection Darzalex Faspro (Daratumumab) Injection is used in the treatment of: • Multiple Myeloma • Relapsed or Refractory Multiple Myeloma • Newly Diagnosed Multiple Myeloma (in combination therapy) It is commonly used together with other anticancer medicines such as lenalidomide, bortezomib, or dexamethasone. How Darzalex Faspro Injection Works Daratumumab works by targeting the CD38 protein found on multiple myeloma cells. By binding to this protein, the medicine helps the immune system recognize and destroy cancer cells. Administration Darzalex Faspro 1800mg Injection should only be administered by a qualified healthcare professional. • Administered subcutaneously (under the skin) • Injection usually takes 3–5 minutes • Treatment schedule depends on the patient’s treatment plan and response Possible Side Effects Some patients may experience: • Fatigue • Nausea • Injection site reactions • Low blood cell counts • Fever • Increased risk of infections Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store at 2°C – 8°C (Refrigerated) • Do not freeze • Protect from light • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us